Amylyx Pharmaceuticals | LinkedIn
Amylyx (@AmylyxPharma) / Twitter
Media
FDA sets decision date for Amylyx Pharma ALS drug that improves neuron survival - MedCity News
Fierce Biotech Names Amylyx Pharmaceuticals as One of Its “Fierce 15” Biotech Companies of 2020 | Business Wire
Amylyx Pharmaceuticals sur LinkedIn : Amylyx Pharmaceuticals Announces ALBRIOZA™ is Now Available in Canada for… | 23 commentaires
Media
Relyvrio Approved as ALS Treatment by the FDA - Xtalks
Gina Mazzariello on LinkedIn: I am excited and privileged to join Amylyx Pharmaceuticals and support
AMYLYX-PHARMACEUTICALS Press Release Archive
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IOKLMV5D5RNP7FTEWUHMHQCFGU.jpg "Amylyx's ALS drug gets U.S. FDA panel's backing in rare turnaround | Reuters")
Amylyx's ALS drug gets U.S. FDA panel's backing in rare turnaround | Reuters
Media
ALS drug wins FDA approval despite questionable data
Media
Amylyx - FINN Partners
Amylyx Donates CENTAUR Records to PRO-ACT Trials Database for ALS | Data From ALS Trial's Placebo Arm Now Freely Available to Researchers | ALS News Today
Amylyx – AMX0035 August 2022
Amylyx Pharmaceuticals Inc.: Stock Market News and Information
Media
Amylyx Seeks U.S. Approval of AMX0035 for ALS With FDA Filing
Amylyx wins approval for first ALS drug - Boston Business Journal
Community Conversation with Amylyx - YouTube
Amylyx Enrolls First ALS Patients in Phase 2 Extension Trial of AMX0035
Amylyx's ALS drug faces tough FDA scrutiny—again
